 Gland PharmaPharmaceuticals | Gland Pharma gets USFDA approval for Sugammadex Injection, Day 1 launch29 Jul 2026Regulatory Product Approval | +3.6% +6.1% — | ₹2,812 | 46,331 Cr | 36.9vs 28.5 | 13.4% | +17.2% |
 DR. Reddy S LaboratoriesPharmaceuticals | Dr Reddy's confirms Thailand approval for gonorrhoea drug NUZOLVENCE29 Jul 2026Regulatory Product Approval | +0.9% +3.0% — | ₹1,175 | 98,087 Cr | 34.2vs 28.5 | 13.0% | -14.5% |
 Alembic PharmaPharmaceuticals | Alembic Pharma gets USFDA nod for Prucalopride Tablets 1mg and 2mg28 Jul 2026Regulatory Product Approval | -0.7% +2.4% — | ₹819 | 16,093 Cr | 24.0vs 28.5 | 11.2% | -3.3% |
 Meghna Infracon Infra LResidential, Commercial Projects | Meghna Infracon delivers Riviera project in Goregaon in 16 months28 Jul 2026Regulatory Product Approval | -0.4% -3.0% — | ₹708 | 1,538 Cr | 226.9vs 17.4 | 33.9% | +52.5% |
 CiplaPharmaceuticals | Cipla gets US FDA approval for Generic Advair Diskus27 Jul 2026Regulatory Product Approval | +4.2% +4.4% — | ₹1,432 | 1.16 L Cr | 47.0vs 28.5 | 14.7% | -13.8% |
 Accord Transformer & SwitchgeaHeavy Electrical Equipment | Q1 FY27 update: ₹159 Cr order book, PGCIL vendor approval27 Jul 2026Regulatory Product Approval | +9.9% +21.2% — | ₹60 | 123 Cr | 29.6vs 33.9 | 12.2% | — |
 Supreme Holdin N Hosp I LResidential Commercial Projects | CIDCO approves 3 extra floors at Belmac Infinity, project revised from G+10 to G+1327 Jul 2026Regulatory Product Approval | +0.9% +2.0% — | ₹41.39 | 160 Cr | 1034.8vs 22.3 | 0.1% | +2243.6% |
 Goodluck IndiaIron & Steel Products | Subsidiary Gets Defence Quality Certification for Artillery Shells27 Jul 2026Regulatory Product Approval | +0.2% +0.5% — | ₹490 | 1,630 Cr | 7.9vs 16.9 | 13.5% | +9.8% |
 EbixHotels & Resorts | EbixCash Wallet Integrates with BHIM UPI27 Jul 2026Regulatory Product Approval | +1.6% -7.0% — | ₹19.74 | 408 Cr | 1.3vs 22.9 | -9.2% | -5.1% |
 Rhetan TMTIron & Steel Products | BIS Certification for Premium TMT Grades Opens Government and PSU Market27 Jul 2026Regulatory Product Approval | +4.1% +13.9% — | ₹24.22 | 1,930 Cr | 86.5vs 16.9 | 9.7% | +78.5% |
 Indo Tech TransformINDOTECH | Enters 400 kV transformer segment with NTPC approval and initial order24 Jul 2026Regulatory Product Approval | +1.9% +5.6% — | ₹3,895 | 4,136 Cr | 42.4 | 32.4% | +30.7% |
 Jeevan Scientific Technology LHealthcare Research, Analytics & Technology | USFDA inspection closed with zero observations at Hyderabad facility24 Jul 2026Regulatory Product Approval | +5.8% +8.0% — | ₹73.35 | 146 Cr | 16.4 | 2.4% | +111.6% |
 Kwality Pharmaceuticals LPharmaceuticals | Kwality Pharma gets CDSCO nod for Pembroluzimab preclinical batches24 Jul 2026Regulatory Product Approval | +1.2% -3.0% — | ₹3,350 | 3,476 Cr | 51.6vs 28.5 | 24.4% | +35.8% |
